Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated: April 2, 2026, 3:58 am
Author: Getaka|Social: XLinkedIn
Stock Ticker - BSE: 532067 | NSE: 3BBLACKBIO

3B Blackbio DX Ltd: Intrinsic Value & Share Price Analysis

Fair Value

₹929.54Overvalued by 19.45%vs CMP ₹1,154.00

P/E (17.2) × ROE (19.4%) × BV (₹347.00) × DY (0.35%)

₹907.21Overvalued by 21.39%vs CMP ₹1,154.00
MoS: -27.2% (Negative)Confidence: 58/100 (Moderate)Models: 1 Under, 1 Fair, 7 Over
ModelCategoryValueWeightSignal
PE-ROEEarnings₹1,016.0322%Over (-12%)
Graham NumberEarnings₹722.8316%Over (-37.4%)
Earnings PowerEarnings₹326.7011%Over (-71.7%)
DCFCash Flow₹1,091.4313%Fair (-5.4%)
Net Asset ValueAssets₹348.187%Over (-69.8%)
EV/EBITDAEnterprise₹475.119%Over (-58.8%)
Earnings YieldEarnings₹669.207%Over (-42%)
ROCE CapitalReturns₹2,934.289%Under (+154.3%)
Revenue MultipleRevenue₹111.795%Over (-90.3%)
Consensus (9 models)₹907.21100%Overvalued
Key Drivers: Wide model spread (₹112–₹2,934) — high uncertainty.

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: 9.3%

*Investments are subject to market risks

Analyst Summary

3B Blackbio DX Ltd operates in the Agro Chemicals/Pesticides segment, NSE: 3BBLACKBIO | BSE: 532067, current market price is ₹1,154.00, market cap is 991 Cr.. At a glance, stock P/E is 17.2, ROE is 19.4 %, ROCE is 25.8 %, book value is 347, dividend yield is 0.35 %. The latest intrinsic value estimate is ₹907.21, around 21.4% below the current price, so expectations may already be running ahead of this modelled fair value. On operating trend, latest reported sales are about ₹96 Cr versus the prior period change of 29.7%, while latest net profit is about ₹48 Cr with a prior-period change of 50.0%. This analysis page also carries profit and loss, shareholding pattern, ratio panels data, which improves the depth of the template beyond a thin price-only snapshot. The 52-week range shown on this page is 2,020/1,120, which helps frame where the current quote sits within its recent trading band. Business context: About the Company - Qualitative Analysis3B BlackBio Dx Ltd. is a Public Limited Listed company incorporated on 27/05/1972 and has its registered office in the State of Madhya Pradesh, India. Company's Corporate Identification Number(CIN) is L24211MP1972PLC001131 and registration number is 001131. Currently Company is i…

This summary is generated from the stock page data available for 3B Blackbio DX Ltd: Intrinsic Value & Share Price Analysis and is refreshed automatically when the underlying metrics change.

Investment Snapshot

68
3B Blackbio DX Ltd scores 68/100 (Average)
Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison
Stock Health92/100 · Strong
ROCE 25.8% ExcellentROE 19.4% ExcellentD/E 0.01 Low debtInterest Coverage 0.0x RiskyProfitable 5/5 years Consistent
Smart Money60/100 · Moderate
FII holding up 0.08% (6mo) Slight increasePromoter holding at 41.3% Stable
Earnings Quality40/100 · Moderate
OPM stable around 48% SteadyWorking capital: 169 days Capital intensive
Quarterly Momentum68/100 · Strong
Revenue (4Q): +33% YoY AcceleratingProfit (4Q): +21% YoY PositiveOPM: 43.0% (down 16.0% YoY) Margin pressure
Industry Rank75/100 · Strong
P/E 17.2 vs industry 25.3 Cheaper than peersROCE 25.8% vs industry 15.2% Above peers3Y sales CAGR: 6% Slow

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily. Not investment advice.

Share Price and Basic Stock Data

Last Updated: April 2, 2026, 3:58 am

Market Cap 991 Cr.
Current Price 1,154
Intrinsic Value₹907.21
High / Low 2,020/1,120
Stock P/E17.2
Book Value 347
Dividend Yield0.35 %
ROCE25.8 %
ROE19.4 %
Face Value 10.0
PEG Ratio1.85

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for 3B Blackbio DX Ltd

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
3B Blackbio DX Ltd 991 Cr. 1,154 2,020/1,12017.2 3470.35 %25.8 %19.4 % 10.0
Meghmani Organics Ltd 1,076 Cr. 42.3 106/36.426.6 60.60.00 %3.39 %0.80 % 1.00
Excel Industries Ltd 1,109 Cr. 882 1,440/80014.6 1,4381.56 %7.11 %5.21 % 5.00
Punjab Chemicals & Crop Protection Ltd 1,138 Cr. 928 1,666/80417.8 3260.32 %15.3 %12.0 % 10.0
Dharmaj Crop Guard Ltd 803 Cr. 238 391/17516.6 1310.00 %12.0 %9.28 % 10.0
Industry Average9,472.25 Cr1,009.7725.27369.000.53%15.21%19.87%6.67

All Competitor Stocks of 3B Blackbio DX Ltd

Quarterly Result

MetricDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales 15181419182319292522223450
Expenses 7118119138131015101929
Operating Profit 77689101116158121522
OPM % 50%41%45%41%50%43%56%55%59%35%53%43%43%
Other Income 3133344335466
Interest 0000000000000
Depreciation 0000000000010
Profit before tax 108910111414191813162027
Tax % 22%38%22%26%24%36%21%23%24%36%20%23%16%
Net Profit 8578991115138131522
EPS in Rs 8.967.729.7110.4610.1610.3312.9717.0715.619.7914.6717.1425.32

Last Updated: March 3, 2026, 1:42 pm

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 26, 2026, 12:46 pm

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 2219171623232922781627496129
Expenses 21181614181620774433414673
Operating Profit 11235791503729335056
OPM % 6%7%9%16%23%31%32%66%46%47%44%52%44%
Other Income 0000012377131520
Interest 1111100000000
Depreciation 0000011111112
Profit before tax 000157101524335446475
Tax % 14%23%23%19%24%25%23%25%26%27%28%25%
Net Profit 00013581143226324858
EPS in Rs 0.590.360.511.765.358.1810.24151.6642.8934.5537.4055.5766.92
Dividend Payout % 0%0%0%17%9%6%7%6%24%8%8%7%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)200.00%66.67%60.00%1325.00%-71.93%-18.75%23.08%50.00%
Change in YoY Net Profit Growth (%)0.00%-133.33%-6.67%1265.00%-1396.93%53.18%41.83%26.92%

3B Blackbio DX Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 8 years from 2017-2018 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:18%
5 Years:27%
3 Years:6%
TTM:25%
Compounded Profit Growth
10 Years:70%
5 Years:44%
3 Years:14%
TTM:34%
Stock Price CAGR
10 Years:71%
5 Years:32%
3 Years:57%
1 Year:-3%
Return on Equity
10 Years:29%
5 Years:30%
3 Years:17%
Last Year:19%

Last Updated: September 5, 2025, 1:56 pm

Balance Sheet

Last Updated: December 4, 2025, 2:15 am

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital 6666667779999
Reserves 4445121625125146185214260290
Borrowings 7889664232100
Other Liabilities 7766689593719242742
Total Liabilities 24252426303645194192214248296341
Fixed Assets 44334445787717
CWIP 0000000000000
Investments 0000001599392117156160
Other Assets 2021212226324013093114123132163
Total Assets 24252426303645194192214248296341

Reserves and Borrowings Chart

Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity + 00112479837202743
Cash from Investing Activity + -0-0-0-0-1-1-1-70-2815-20-33
Cash from Financing Activity + 0-0-1-00-11-2-15-5-4-3
Net Cash Flow 0-00012726-63037
Free Cash Flow -00101369635182642
CFO/OP 25%23%69%36%52%71%101%90%129%100%115%116%

Free Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow-6.00-7.00-6.00-6.00-1.001.005.00148.0034.0027.0032.0050.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 21326228332125929025256136200179138
Inventory Days 120145143175164141124
Days Payable 189218203186696628
Cash Conversion Cycle 14418822331025929025256136296253235
Working Capital Days 14417520524725328727565162241215169
ROCE %7%7%7%13%24%28%31%162%27%19%21%26%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoters 38.43%38.43%38.43%38.43%41.29%41.28%41.28%41.28%41.28%41.28%41.28%41.27%
FIIs 2.54%3.06%3.16%3.38%2.97%3.28%3.27%2.68%2.49%2.70%2.64%2.57%
DIIs 0.00%0.00%0.82%1.18%1.89%1.96%1.96%1.74%1.60%1.76%1.82%1.87%
Public 59.02%58.50%57.60%56.99%53.85%53.48%53.48%54.29%54.64%54.28%54.26%54.27%
No. of Shareholders 13,13612,41610,51310,0889,7539,3999,58610,16610,34510,61910,70910,507

Shareholding Pattern Chart

No. of Shareholders

3B Blackbio DX Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

This stock is not held by any mutual fund.

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 10.0010.0010.0010.0010.00
Basic EPS (Rs.) 55.5737.4034.5543.40151.66
Diluted EPS (Rs.) 55.5737.4034.5543.40151.66
Cash EPS (Rs.) 56.9338.7035.7743.88152.82
Book Value[Excl.RevalReserv]/Share (Rs.) 313.27263.15261.50229.69197.92
Book Value[Incl.RevalReserv]/Share (Rs.) 313.27263.15261.50229.69197.92
Revenue From Operations / Share (Rs.) 112.5986.5182.54107.65302.66
PBDIT / Share (Rs.) 76.0853.1248.5558.73204.07
PBIT / Share (Rs.) 74.8251.8847.4057.84203.25
PBT / Share (Rs.) 74.6951.7447.1357.69202.94
Net Profit / Share (Rs.) 55.6637.4634.6242.98152.00
NP After MI And SOA / Share (Rs.) 55.6637.4634.6242.98152.00
PBDIT Margin (%) 67.5761.4058.8154.5667.42
PBIT Margin (%) 66.4559.9757.4253.7267.15
PBT Margin (%) 66.3459.8057.1053.5967.05
Net Profit Margin (%) 49.4343.3041.9439.9250.21
NP After MI And SOA Margin (%) 49.4343.3041.9439.9250.21
Return on Networth / Equity (%) 17.7614.3915.1421.0486.23
Return on Capital Employeed (%) 23.1319.2817.7624.73101.13
Return On Assets (%) 16.1212.9312.1116.7658.83
Long Term Debt / Equity (X) 0.000.000.010.010.01
Total Debt / Equity (X) 0.000.000.010.010.01
Asset Turnover Ratio (%) 0.350.320.300.130.38
Current Ratio (X) 7.117.048.054.822.76
Quick Ratio (X) 6.646.567.494.382.64
Inventory Turnover Ratio (X) 11.242.412.332.662.68
Interest Coverage Ratio (X) 600.85365.87183.32413.58669.53
Interest Coverage Ratio (Post Tax) (X) 440.55259.05131.73303.65499.68
Enterprise Value (Cr.) 1319.35600.55278.94248.35196.43
EV / Net Operating Revenue (X) 13.688.104.513.080.86
EV / EBITDA (X) 20.2413.197.675.641.28
MarketCap / Net Operating Revenue (X) 14.368.905.043.170.94
Price / BV (X) 5.162.961.821.671.62
Price / Net Operating Revenue (X) 14.368.905.043.170.94
EarningsYield 0.030.040.080.120.53

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

About the Company - Qualitative Analysis

3B BlackBio Dx Ltd. is a Public Limited Listed company incorporated on 27/05/1972 and has its registered office in the State of Madhya Pradesh, India. Company's Corporate Identification Number(CIN) is L24211MP1972PLC001131 and registration number is 001131. Currently Company is involved in the business activities of Manufacture of pesticides and other agrochemical products. Company's Total Operating Revenue is Rs. 90.53 Cr. and Equity Capital is Rs. 8.57 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
Agro Chemicals/Pesticides7-C, Industrial Area, Bhopal Madhya Pradesh 462023Contact not found
Management
NamePosition Held
Mr. Dhirendra DubeyChairman & Managing Director
Mr. N K DubeyWhole Time Director
Mr. Harihar Prasad ThapakIndependent Director
Mr. Abdul Moin KhanIndependent Director
Mrs. Mithala DubeyDirector
Mr. Vivek SaihgalAdditional Director

FAQ

What is the intrinsic value of 3B Blackbio DX Ltd and is it undervalued?

As of 20 April 2026, 3B Blackbio DX Ltd's intrinsic value is ₹907.21, which is 21.39% lower than the current market price of ₹1,154.00, suggesting the stock is overvalued. This is calculated using the PE ratio method factoring in ROE (19.4 %), book value (₹347), dividend yield (0.35 %), and 5-year EPS CAGR.

What is the current share price and 52-week range of 3B Blackbio DX Ltd?

3B Blackbio DX Ltd is trading at ₹1,154.00 as of 20 April 2026, with a FY2026-2027 high of ₹2,020 and low of ₹1,120. The stock is currently near its 52-week low. Market cap stands at ₹991 Cr..

How does 3B Blackbio DX Ltd's P/E ratio compare to its industry?

3B Blackbio DX Ltd has a P/E ratio of 17.2, which is below the industry average of 25.27. This is broadly in line with or below the industry average.

Is 3B Blackbio DX Ltd financially healthy?

Key indicators for 3B Blackbio DX Ltd: ROCE of 25.8 % indicates efficient capital utilization; ROE of 19.4 % shows strong shareholder returns. Dividend yield is 0.35 %.

Is 3B Blackbio DX Ltd profitable and how is the profit trend?

3B Blackbio DX Ltd reported a net profit of ₹48 Cr in Mar 2025 on revenue of ₹96 Cr. Compared to ₹32 Cr in Mar 2022, the net profit shows an improving trend.

Does 3B Blackbio DX Ltd pay dividends?

3B Blackbio DX Ltd has a dividend yield of 0.35 % at the current price of ₹1,154.00. The company pays dividends, though the yield is modest.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in 3B Blackbio DX Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
Explore Industry-wise Stock Analysis Reports